Safety of rituximab in rheumatoid arthritis
Patients with rheumatoid arthritis (RA) are at increased risk of manifestations such as serious infectious events (SIEs), malignancies and cardiovascular disease (1). Moreover, a long administration of drugs is required in this chronic disease, a condition that is responsible of a greater risk of si...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
PAGEPress Publications
2011-06-01
|
| Серія: | Reumatismo |
| Онлайн доступ: | http://www.reumatismo.org/index.php/reuma/article/view/470 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|